Colucid Pharma Cmn (CLCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 83,540 | 13,812 | 23,486 | 27,978 | 36,019 |
| Marketable Securities | 16,641 | 26,514 | 27,595 | 36,530 | 33,149 |
| TOTAL | $100,950 | $41,273 | $52,219 | $65,317 | $70,702 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 1,512 | 3,018 | 0 | 4,929 |
| Other Non-Current Assets | 21 | 21 | 21 | 21 | 21 |
| TOTAL | $21 | $1,533 | $3,039 | $21 | $4,950 |
| Total Assets | $100,971 | $42,806 | $55,258 | $65,338 | $75,651 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,151 | 4,778 | 3,330 | 1,649 | 2,628 |
| Accrued Expenses | 4,782 | 5,480 | 3,972 | 3,780 | 3,003 |
| TOTAL | $8,933 | $10,258 | $7,302 | $5,429 | $5,631 |
| Non-Current Liabilities | |||||
| TOTAL | $1,500 | $1,500 | $1,500 | $1,500 | $1,500 |
| Total Liabilities | $10,433 | $11,758 | $8,802 | $6,929 | $7,131 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,247 | 15,335 | 15,275 | 15,275 | 15,153 |
| Common Shares | 19 | 15 | 15 | 15 | 15 |
| Retained earnings | -129,089 | -116,432 | -100,155 | -87,095 | -75,866 |
| Other shareholders' equity | 7 | 19 | 4 | -43 | -9 |
| TOTAL | $90,538 | $31,048 | $46,456 | $58,409 | $68,521 |
| Total Liabilities And Equity | $100,971 | $42,806 | $55,258 | $65,338 | $75,651 |